{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T04:02:46Z","timestamp":1745294566335,"version":"3.40.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.7759\/cureus.82689","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T12:49:51Z","timestamp":1745239791000},"source":"Crossref","is-referenced-by-count":0,"title":["Ectopic Adrenocorticotropic Hormone Production in a Stage IV Neuroendocrine Tumor: A Rare Presentation of Cushing's Syndrome"],"prefix":"10.7759","author":[{"given":"Faisal","family":"Aljabrain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Strobelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict","family":"Cu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix A","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015, 386:913-27. 10.1016\/S0140-6736(14)61375-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1963.03620280071011","article-title":"Nonpituitary neoplasms and Cushing's syndrome. Ectopic \"adrenocorticotropin\" produced by nonpituitary neoplasms as a cause of Cushing's syndrome","volume":"111","author":"Liddle GW","year":"1963","unstructured":"Liddle GW, Island DP, Ney RL, Nicholson WE, Shimizu N. Nonpituitary neoplasms and Cushing's syndrome. Ectopic \"adrenocorticotropin\" produced by nonpituitary neoplasms as a cause of Cushing's syndrome. Arch Intern Med. 1963, 111:471-5. 10.1001\/archinte.1963.03620280071011","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-22-0378","article-title":"Ectopic Cushing's syndrome: clinical, diagnostic, treatment and follow-up outcomes of 12 cases of lung ectopic ACTH","volume":"2023","author":"Gonz\u00e1lez Fern\u00e1ndez L","year":"2023","unstructured":"Gonz\u00e1lez Fern\u00e1ndez L, Maricel Rivas Montenegro A, Brox Torrecilla N, et al.. Ectopic Cushing's syndrome: clinical, diagnostic, treatment and follow-up outcomes of 12 cases of lung ectopic ACTH. Endocrinol Diabetes Metab Case Rep. 2023, 2023:22-0378. 10.1530\/EDM-22-0378","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00972-w","article-title":"Diagnostic utility of gallium-68-somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience","volume":"22","author":"Varlamov E","year":"2019","unstructured":"Varlamov E, Hinojosa-Amaya JM, Stack M, Fleseriu M. Diagnostic utility of gallium-68-somatostatin receptor PET\/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience. Pituitary. 2019, 22:445-55. 10.1007\/s11102-019-00972-w","journal-title":"Pituitary"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi' MV","year":"2017","unstructured":"Davi' MV, Cosaro E, Piacentini S, et al.. Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017, 176:453-61. 10.1530\/EJE-16-0809","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome","volume":"105","author":"Frete C","year":"2020","unstructured":"Frete C, Corcuff JB, Kuhn E, et al.. Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab. 2020, 105:3273-84. 10.1210\/clinem\/dgaa409","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15024","article-title":"Diagnostic role of PET\/CT tracers in the detection and localization of tumours responsible for ectopic Cushing's syndrome","volume":"41","author":"Zisser L","year":"2021","unstructured":"Zisser L, Kulterer OC, Itariu B, et al.. Diagnostic role of PET\/CT tracers in the detection and localization of tumours responsible for ectopic Cushing's syndrome. Anticancer Res. 2021, 41:2477-84. 10.21873\/anticanres.15024","journal-title":"Anticancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi M","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, et al.. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016, 103:153-71. 10.1159\/000443171","journal-title":"Neuroendocrinology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano R","year":"2015","unstructured":"Maragliano R, Vanoli A, Albarello L, et al.. ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol. 2015, 39:374-82. 10.1097\/PAS.0000000000000340","journal-title":"Am J Surg Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa507","article-title":"The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors","volume":"105","author":"Zhang C","year":"2020","unstructured":"Zhang C, Jin J, Xie J, et al.. The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2020, 105:3449-58. 10.1210\/clinem\/dgaa507","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13336","article-title":"ACTH-secreting pancreatic neuroendocrine neoplasms: a case-series","volume":"35","author":"Al-Toubah T","year":"2023","unstructured":"Al-Toubah T, Pelle E, Hallanger-Johnson J, Haider M, Strosberg J. ACTH-secreting pancreatic neuroendocrine neoplasms: a case-series. J Neuroendocrinol. 2023, 35:e13336. 10.1111\/jne.13336","journal-title":"J Neuroendocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2020.10.012","article-title":"Adrenocorticotropic hormone-producing pancreatic neuroendocrine neoplasms: a systematic review","volume":"27","author":"Wu Y","year":"2021","unstructured":"Wu Y, Xiong G, Zhang H, Wang M, Zhu F, Qin R. Adrenocorticotropic hormone-producing pancreatic neuroendocrine neoplasms: a systematic review. Endocr Pract. 2021, 27:152-7. 10.1016\/j.eprac.2020.10.012","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.31.407","article-title":"Disproportionate hypertrophy of the interventricular septum and its regression in Cushing's syndrome. Report of three cases","volume":"31","author":"Sugihara N","year":"1992","unstructured":"Sugihara N, Shimizu M, Shimizu K, Ino H, Miyamori I, Nakabayashi H, Takeda R. Disproportionate hypertrophy of the interventricular septum and its regression in Cushing's syndrome. Report of three cases. Intern Med. 1992, 31:407-13. 10.2169\/internalmedicine.31.407","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346339","article-title":"Cushing's syndrome patient who exhibited congestive heart failure","volume":"30","author":"Petramala L","year":"2007","unstructured":"Petramala L, Battisti P, Lauri G, et al.. Cushing's syndrome patient who exhibited congestive heart failure. J Endocrinol Invest. 2007, 30:525-8. 10.1007\/BF03346339","journal-title":"J Endocrinol Invest"},{"key":"ref15","article-title":"Left ventricular structural characteristics in Cushing's syndrome","volume":"8","author":"Fallo F","year":"1994","unstructured":"Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M. Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens. 1994, 8:509-13.","journal-title":"J Hum Hypertens"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0601","article-title":"Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome","volume":"166","author":"Yiu KH","year":"2012","unstructured":"Yiu KH, Marsan NA, Delgado V, et al.. Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome. Eur J Endocrinol. 2012, 166:27-34. 10.1530\/EJE-11-0601","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2022.03.014","article-title":"Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome","volume":"172","author":"Landry JP","year":"2022","unstructured":"Landry JP, Clemente-Gutierrez U, Pieterman CR, et al.. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022, 172:559-66. 10.1016\/j.surg.2022.03.014","journal-title":"Surgery"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01461.x","article-title":"Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours","volume":"36","author":"Cheung NW","year":"1992","unstructured":"Cheung NW, Boyages SC. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours. Clin Endocrinol (Oxf). 1992, 36:361-7. 10.1111\/j.1365-2265.1992.tb01461.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211252","article-title":"Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide","volume":"101","author":"De Rosa G","year":"1993","unstructured":"De Rosa G, Testa A, Liberale I, Pirronti T, Granone P, Picciocchi A. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide. Exp Clin Endocrinol. 1993, 101:319-25. 10.1055\/s-0029-1211252","journal-title":"Exp Clin Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha M","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M. Cushing's syndrome. Lancet. 2023, 402:2237-52. 10.1016\/S0140-6736(23)01961-X","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4158\/EP12149.RA","article-title":"A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone","volume":"19","author":"Fleseriu M","year":"2013","unstructured":"Fleseriu M, Molitch ME, Gross C, Schteingart DE, Vaughan TB 3rd, Biller BM. A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone. Endocr Pract. 2013, 19:313-26. 10.4158\/EP12149.RA","journal-title":"Endocr Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2021.1945440","article-title":"Levoketoconazole: a novel treatment for endogenous Cushing's syndrome","volume":"16","author":"Fleseriu M","year":"2021","unstructured":"Fleseriu M, Auchus RJ, Pivonello R, Salvatori R, Zacharieva S, Biller BM. Levoketoconazole: a novel treatment for endogenous Cushing's syndrome. Expert Rev Endocrinol Metab. 2021, 16:159-74. 10.1080\/17446651.2021.1945440","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0483-3","article-title":"Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations","volume":"17","author":"Colao A","year":"2014","unstructured":"Colao A, De Block C, Gaztambide MS, Kumar S, Seufert J, Casanueva FF. Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations. Pituitary. 2014, 17:180-6. 10.1007\/s11102-013-0483-3","journal-title":"Pituitary"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0582-9","article-title":"Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations","volume":"18","author":"Trementino L","year":"2015","unstructured":"Trementino L, Cardinaletti M, Concettoni C, Marcelli G, Boscaro M, Arnaldi G. Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations. Pituitary. 2015, 18:359-65. 10.1007\/s11102-014-0582-9","journal-title":"Pituitary"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf027","article-title":"Osilodrostat treatment for adrenal and ectopic Cushing syndrome: integration of clinical studies with case presentations","volume":"9","author":"Fleseriu M","year":"2025","unstructured":"Fleseriu M, Auchus RJ, Bancos I, Biller BM. Osilodrostat treatment for adrenal and ectopic Cushing syndrome: integration of clinical studies with case presentations. J Endocr Soc. 2025, 9:bvaf027. 10.1210\/jendso\/bvaf027","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351968-ectopic-adrenocorticotropic-hormone-production-in-a-stage-iv-neuroendocrine-tumor-a-rare-presentation-of-cushings-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T12:49:51Z","timestamp":1745239791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351968-ectopic-adrenocorticotropic-hormone-production-in-a-stage-iv-neuroendocrine-tumor-a-rare-presentation-of-cushings-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.82689","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}